StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) operating KPIs

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 17/3023% above fair value
$432.01−16.75 (-3.73%)

Close on Oct 30, 2026Market cap $152.62BP/E 49.5Yield –

Intuitive Surgical u.S. MedTech Industry Total — FDA Premarket Approvals (PMA & Supplements)

U.S. FDA openFDA API (/device/pma)

QuarterlyAnnualMonthly
Latest, Q3 2026
565
Period ended Sep 30, 2026
Change on a year earlier
-3.4%
585 in Q3 2025
History
51 quarters
Since Q1 2014
Sources
1
https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR)

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedU.S. MedTech Industry Total — FDA Premarket Approvals (PMA & Supplements)Year on yearSource
Q3 2026Sep 30, 2026565-3.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2026Jun 30, 2026608+3.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2026Mar 31, 2026567+8.2%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2025Dec 31, 2025525-23.1%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2025Sep 30, 2025585+8.7%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2025Jun 30, 2025588+6.9%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2025Mar 31, 2025524+14.2%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2024Dec 31, 2024683+4.1%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2024Sep 30, 2024538-1.1%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2024Jun 30, 2024550-1.4%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2024Mar 31, 2024459+7.5%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2023Dec 31, 2023656+11.9%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q3 2023Sep 30, 2023544+11.2%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q2 2023Jun 30, 2023558+16.5%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q1 2023Mar 31, 2023427-20.6%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗
Q4 2022Dec 31, 2022586+2.6%https://api.fda.gov/device/ (U.S. FDA openFDA Device Clearances, Approvals, Recalls & MAUDE MDR) ↗

Cite this data

StockData. (2026). Intuitive Surgical U.S. MedTech Industry Total — FDA Premarket Approvals (PMA & Supplements), quarterly Q1 2014–Q3 2026 [Data set]. Compiled from Intuitive Surgical SEC filings and investor materials. https://stockdatahq.com/stocks/isrg/kpis/ext-fda-pma-us

See every metric in the Intuitive Surgical KPI table. Data updated Oct 28, 2026.